- Home
- SOGP vs CSCI Comparison
SOGP vs CSCI Comparison
Compare SOGP & CSCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOGP
- CSCI
- Stock Information
- Founded
- SOGP 2010
- CSCI 1990
- Country
- SOGP Singapore
- CSCI Canada
- Employees
- SOGP N/A
- CSCI N/A
- Industry
- SOGP
- CSCI
- Sector
- SOGP
- CSCI
- Exchange
- SOGP NYSE
- CSCI NYSE
- Market Cap
- SOGP 10.0M
- CSCI 11.1M
- IPO Year
- SOGP 2020
- CSCI 1996
- Fundamental
- Price
- SOGP $1.96
- CSCI $2.80
- Analyst Decision
- SOGP
- CSCI
- Analyst Count
- SOGP 0
- CSCI 0
- Target Price
- SOGP N/A
- CSCI N/A
- AVG Volume (30 Days)
- SOGP 46.6K
- CSCI 12.4K
- Earning Date
- SOGP 01-01-0001
- CSCI 03-26-2025
- Dividend Yield
- SOGP N/A
- CSCI N/A
- EPS Growth
- SOGP N/A
- CSCI N/A
- EPS
- SOGP N/A
- CSCI N/A
- Revenue
- SOGP $250,401,822.00
- CSCI $4,834,000.00
- Revenue This Year
- SOGP $37.39
- CSCI N/A
- Revenue Next Year
- SOGP $3.88
- CSCI N/A
- P/E Ratio
- SOGP N/A
- CSCI N/A
- Revenue Growth
- SOGP N/A
- CSCI N/A
- 52 Week Low
- SOGP $1.49
- CSCI $2.38
- 52 Week High
- SOGP $6.70
- CSCI $11.10
- Technical
- Relative Strength Index (RSI)
- SOGP 49.48
- CSCI N/A
- Support Level
- SOGP $1.92
- CSCI N/A
- Resistance Level
- SOGP $2.24
- CSCI N/A
- Average True Range (ATR)
- SOGP 0.21
- CSCI 0.00
- MACD
- SOGP 0.01
- CSCI 0.00
- Stochastic Oscillator
- SOGP 37.81
- CSCI 0.00
About SOGP SOUND GROUP INC SPON ADS EA REP 200 ORD SHS(POST SPLIT)
Sound Group Inc is a world-wide audio-centric social and entertainment company. It Leverages broad product portfolio and in-house technologies, Sound Group caters to user interest in audio entertainment and social networking. Sound Group nurtures a globally diverse and inclusive team, drawing on talent from various countries and regions world-wide.
About CSCI COSCIENS BIOPHARMA INC
Cosciens Biopharma Inc is a biopharmaceutical company developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products and active ingredients for healthcare and cosmetics industries. The company is engaged in the development of therapeutic assets and proprietary extraction technology.